How to buy Collegium Pharmaceutical stock (COLL)

Collegium Pharmaceutical is a drug manufacturers - specialty & generic business based in the US. Collegium Pharmaceutical shares (COLL) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $35.24 – a decrease of 2.63% over the previous week. Collegium Pharmaceutical employs 197 staff and has a trailing 12-month revenue of around $576.7 million.

Our top picks for where to buy Collegium Pharmaceutical stock

Buy Collegium Pharmaceutical stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Collegium Pharmaceutical stock price (NASDAQ: COLL)

Use our graph to track the performance of COLL stocks over time.

Collegium Pharmaceutical shares at a glance

• Key figures

Information last updated 2024-10-25.

Latest market close	$35.24
52-week range	$21.11 - $42.29
50-day moving average more info button	$37.61
200-day moving average more info button	$35.47
Wall St. target price	$43.25
PE ratio more info button	12.8985
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$2.66

Is it a good time to buy Collegium Pharmaceutical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Collegium Pharmaceutical price performance over time

Historical closes compared with the close of $35.13 from 2024-10-28

1 week (2024-10-22)	-2.93%
1 month (2024-09-30)	-9.08%
3 months (2024-07-30)	-8.99%
6 months (2024-04-30)	-4.87%

1 year (2023-10-30)	61.74%
2 years (2022-10-28)	92.81%
3 years (2021-10-29)	78.96%
5 years (2019-10-30)	193.73%

Is Collegium Pharmaceutical stock undervalued or overvalued?

Valuing Collegium Pharmaceutical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Collegium Pharmaceutical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Collegium Pharmaceutical's P/E ratio

Collegium Pharmaceutical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Collegium Pharmaceutical shares trade at around 13x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Collegium Pharmaceutical's EBITDA

Collegium Pharmaceutical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $347.4 million.

The EBITDA is a measure of a Collegium Pharmaceutical's overall financial performance and is widely used to measure a its profitability.

Collegium Pharmaceutical financials

Revenue TTM	$576.7 million
Operating margin TTM	32.68%
Gross profit TTM	$345.7 million
Return on assets TTM	11.24%
Return on equity TTM	47.87%
Profit margin	17.32%
Book value	$6.70
Market Capitalization more info button	$1.2 billion

TTM: trailing 12 months

Collegium Pharmaceutical share dividends

We're not expecting Collegium Pharmaceutical to pay a dividend over the next 12 months.

Collegium Pharmaceutical share price volatility

Over the last 12 months, Collegium Pharmaceutical's shares have ranged in value from as little as $21.11 up to $42.2873. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Collegium Pharmaceutical's is 0.932. This would suggest that Collegium Pharmaceutical's shares are less volatile than average (for this exchange).

Collegium Pharmaceutical overview

Collegium Pharmaceutical, Inc. , a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc.

Frequently asked questions

null
What percentage of Collegium Pharmaceutical is owned by insiders or institutions?
Currently 1.317% of Collegium Pharmaceutical shares are held by insiders and 125.335% by institutions. How many people work for Collegium Pharmaceutical?
Latest data suggests 197 work at Collegium Pharmaceutical. When does the fiscal year end for Collegium Pharmaceutical?
Collegium Pharmaceutical's fiscal year ends in December. Where is Collegium Pharmaceutical based?
Collegium Pharmaceutical's address is: 100 Technology Center Drive, Stoughton, MA, United States, 02072 What is Collegium Pharmaceutical's ISIN number?
Collegium Pharmaceutical's international securities identification number is: US19459J1043 What is Collegium Pharmaceutical's CUSIP number?
Collegium Pharmaceutical's Committee on Uniform Securities Identification Procedures number is: 19459J104